{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T19:32:16Z","timestamp":1789241536262,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T00:00:00Z","timestamp":1677888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T00:00:00Z","timestamp":1677888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81922012"],"award-info":[{"award-number":["81922012"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000545"],"award-info":[{"award-number":["82000545"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007055","name":"Third Military Medical University","doi-asserted-by":"publisher","award":["XZ-2019-505-071"],"award-info":[{"award-number":["XZ-2019-505-071"]}],"id":[{"id":"10.13039\/501100007055","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s11010-023-04682-7","type":"journal-article","created":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T07:02:47Z","timestamp":1677913367000},"page":"2527-2537","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Melatonin attenuates cholestatic liver injury via inhibition of the inflammatory response"],"prefix":"10.1007","volume":"478","author":[{"given":"Ya","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoling","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,4]]},"reference":[{"key":"4682_CR1","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jhep.2009.05.012","volume":"51","author":"M Wagner","year":"2009","unstructured":"Wagner M, Zollner G, Trauner M (2009) New molecular insights into the mechanisms of cholestasis. J Hepatol 51:565\u2013580. https:\/\/doi.org\/10.1016\/j.jhep.2009.05.012","journal-title":"J Hepatol"},{"key":"4682_CR2","doi-asserted-by":"publisher","first-page":"175628481878740","DOI":"10.1177\/1756284818787400","volume":"11","author":"P Santiago","year":"2018","unstructured":"Santiago P, Scheinberg AR, Levy C (2018) Cholestatic liver diseases: new targets, new therapies. Therap Adv Gastroenterol 11:1756284818787400. https:\/\/doi.org\/10.1177\/1756284818787400","journal-title":"Therap Adv Gastroenterol"},{"key":"4682_CR3","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.14309\/ajg.0000000000000268","volume":"114","author":"RT Yokoda","year":"2019","unstructured":"Yokoda RT, Carey EJ (2019) Primary biliary cholangitis and primary sclerosing cholangitis. Am J Gastroenterol 114:1593\u20131605. https:\/\/doi.org\/10.14309\/ajg.0000000000000268","journal-title":"Am J Gastroenterol"},{"key":"4682_CR4","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.jcmgh.2019.12.008","volume":"9","author":"SY Cai","year":"2020","unstructured":"Cai SY, Ge M, Mennone A, Hoque R, Ouyang X, Boyer JL (2020) Inflammasome is activated in the liver of cholestatic patients and aggravates hepatic injury in bile duct\u2013ligated mouse. Cell Mol Gastroenterol Hepatol 9:679\u2013688. https:\/\/doi.org\/10.1016\/j.jcmgh.2019.12.008","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"4682_CR5","doi-asserted-by":"publisher","first-page":"737","DOI":"10.21037\/atm-20-5110","volume":"9","author":"SY Cai","year":"2021","unstructured":"Cai SY, Boyer JL (2021) The role of bile acids in cholestatic liver injury. Ann Transl Med 9:737. https:\/\/doi.org\/10.21037\/atm-20-5110","journal-title":"Ann Transl Med"},{"key":"4682_CR6","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1210\/er.2018-00084","volume":"39","author":"J Cipolla-Neto","year":"2018","unstructured":"Cipolla-Neto J, Amaral FGD (2018) Melatonin as a hormone: new physiological and clinical insights. Endocr Rev 39:990\u20131028. https:\/\/doi.org\/10.1210\/er.2018-00084","journal-title":"Endocr Rev"},{"key":"4682_CR7","doi-asserted-by":"publisher","first-page":"18886","DOI":"10.3390\/molecules201018886","volume":"20","author":"DX Tan","year":"2015","unstructured":"Tan DX, Manchester LC, Esteban-Zubero E, Zhou Z, Reiter RJ (2015) Melatonin as a potent and inducible endogenous antioxidant: synthesis and metabolism. Molecules 20:18886\u201318906. https:\/\/doi.org\/10.3390\/molecules201018886","journal-title":"Molecules"},{"key":"4682_CR8","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3390\/ijms18040673","volume":"18","author":"JJ Zhang","year":"2017","unstructured":"Zhang JJ, Meng X, Li Y, Zhou Y, Xu DP, Li S, Li HB (2017) Effects of melatonin on liver injuries and diseases. Int J Mol Sci 18:673. https:\/\/doi.org\/10.3390\/ijms18040673","journal-title":"Int J Mol Sci"},{"key":"4682_CR9","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1053\/j.gastro.2018.07.031","volume":"155","author":"Q Pan","year":"2018","unstructured":"Pan Q, Zhang X, Zhang L, Cheng Y, Zhao N, Li F, Zhou X, Chen S, Li J, Xu S, Huang D, Chen Y, Li L, Wang H, Chen W, Cai SY, Boyer JL, Chai J (2018) Solute carrier organic anion transporter family member 3A1 is a bile acid efflux transporter in cholestasis. Gastroenterology 155:1578-1592.e16. https:\/\/doi.org\/10.1053\/j.gastro.2018.07.031","journal-title":"Gastroenterology"},{"key":"4682_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","volume":"67","author":"European Association for the Study of the Liver","year":"2017","unstructured":"European Association for the Study of the Liver (2017) EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis. J Hepatol 67:145\u2013172. https:\/\/doi.org\/10.1016\/j.jhep.2017.03.022","journal-title":"J Hepatol"},{"key":"4682_CR11","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.jhep.2015.07.016","volume":"63","author":"J Chai","year":"2015","unstructured":"Chai J, Cai SY, Liu X, Lian W, Chen S, Zhang L, Feng X, Cheng Y, He X, He Y, Chen L, Wang R, Wang H, Boyer JL, Chen W (2015) Canalicular membrane MRP2\/ABCC2 internalization is determined by Ezrin Thr567 phosphorylation in human obstructive cholestasis. J Hepatol 63:1440\u20131448. https:\/\/doi.org\/10.1016\/j.jhep.2015.07.016","journal-title":"J Hepatol"},{"key":"4682_CR12","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1002\/hep.24801","volume":"55","author":"J Chai","year":"2012","unstructured":"Chai J, He Y, Cai SY, Jiang Z, Wang H, Li Q, Chen L, Peng Z, He X, Wu X, Xiao T, Wang R, Boyer JL, Chen W (2012) Elevated hepatic multidrug resistance-associated protein 3\/ATP-binding cassette subfamily C3 expression in human obstructive cholestasis is mediated through tumor necrosis factor alpha and c-Jun NH2-terminal kinase\/stress-activated protein kinase-signaling pathway. Hepatol 55:1485\u20131494. https:\/\/doi.org\/10.1002\/hep.24801","journal-title":"Hepatol"},{"key":"4682_CR13","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1053\/j.gastro.2008.10.025","volume":"136","author":"SY Cai","year":"2009","unstructured":"Cai SY, Gautam S, Nguyen T, Soroka CJ, Rahner C, Boyer JL (2009) ATP8B1 deficiency disrupts the bile canalicular membrane bilayer structure in hepatocytes, but FXR expression and activity are maintained. Gastroenterology 136:1060\u20131069. https:\/\/doi.org\/10.1053\/j.gastro.2008.10.025","journal-title":"Gastroenterology"},{"key":"4682_CR14","doi-asserted-by":"publisher","first-page":"9667","DOI":"10.3390\/ijms21249667","volume":"21","author":"E Ostrycharz","year":"2020","unstructured":"Ostrycharz E, Wasik U, Kempinska-Podhorodecka A, Banales JM, Milkiewicz P, Milkiewicz M (2020) Melatonin protects cholangiocytes from oxidative stress-induced proapoptotic and proinflammatory stimuli via mir-132 and mir-34. Int J Mol Sci 21:9667. https:\/\/doi.org\/10.3390\/ijms21249667","journal-title":"Int J Mol Sci"},{"key":"4682_CR15","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.1096\/fj.201700097R","volume":"31","author":"N Wu","year":"2017","unstructured":"Wu N, Meng F, Zhou T, Han Y, Kennedy L, Venter J, Francis H, DeMorrow S, Onori P, Invernizzi P, Bernuzzi F, Mancinelli R, Gaudio E, Franchitto A, Glaser S, Alpini G (2017) Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation. FASEB J 31:4305\u20134324. https:\/\/doi.org\/10.1096\/fj.201700097R","journal-title":"FASEB J"},{"key":"4682_CR16","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/hep.30249","volume":"69","author":"A Ambade","year":"2019","unstructured":"Ambade A, Lowe P, Kodys K, Catalano D, Gyongyosi B, Cho Y, Iracheta-Vellve A, Adejumo A, Saha B, Calenda C, Mehta J, Lefebvre E, Vig P, Szabo G (2019) Pharmacological inhibition of CCR2\/5 signaling prevents and reverses alcohol induced liver damage, steatosis, and inflammation in mice. Hepatology 69:1105\u20131121. https:\/\/doi.org\/10.1002\/hep.30249","journal-title":"Hepatology"},{"key":"4682_CR17","doi-asserted-by":"publisher","first-page":"e90780","DOI":"10.1172\/jci.insight.90780","volume":"2","author":"SY Cai","year":"2017","unstructured":"Cai SY, Ouyang X, Chen Y, Soroka CJ, Wang J, Mennone A, Wang Y, Mehal WZ, Jain D, Boyer JL (2017) Bile acids initiate cholestatic liver injury by triggering a hepatocyte-specific inflammatory response. JCI Insight 2:e90780. https:\/\/doi.org\/10.1172\/jci.insight.90780","journal-title":"JCI Insight"},{"key":"4682_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1172\/10.1016\/j.mam.2017.06.001","volume":"56","author":"M Li","year":"2017","unstructured":"Li M, Cai SY, Boyer JL (2017) Mechanisms of bile acid mediated inflammation in the liver. Mol Aspects Med 56:45\u201353. https:\/\/doi.org\/10.1172\/10.1016\/j.mam.2017.06.001","journal-title":"Mol Aspects Med"},{"key":"4682_CR19","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jaut.2016.08.006","volume":"75","author":"S Hisamoto","year":"2016","unstructured":"Hisamoto S, Shimoda S, Harada K, Iwasaka S, Onohara S, Chong Y, Nakamura M, Bekki Y, Yoshizumi T, Ikegami T, Maehara Y, He XS, Gershwin ME, Akashi K (2016) Hydrophobic bile acids suppress expression of AE2 in biliary epithelial cells and induce bile duct inflammation in primary biliary cholangitis. J Autoimmun 75:150\u2013160. https:\/\/doi.org\/10.1016\/j.jaut.2016.08.006","journal-title":"J Autoimmun"},{"key":"4682_CR20","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.3892\/mmr.2018.9746","volume":"19","author":"Y Li","year":"2019","unstructured":"Li Y, Yu H, Xu Z, Shi S, Wang D, Shi X, Wang Y, Zeng B, Deng H, Deng X, Zhong X (2019) Melatonin ameliorates ANIT-induced cholestasis by activating Nrf2 through a PI3K\/Akt-dependent pathway in rats. Mol Med Rep 19:1185\u20131193. https:\/\/doi.org\/10.3892\/mmr.2018.9746","journal-title":"Mol Med Rep"},{"key":"4682_CR21","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3390\/ijms17081365","volume":"17","author":"JM Sheen","year":"2016","unstructured":"Sheen JM, Chen YC, Hsu MH, Tain YL, Huang YH, Tiao MM, Li SW, Huang LT (2016) Melatonin alleviates liver apoptosis in bile duct ligation young rats. Int J Mol Sci 17:1365. https:\/\/doi.org\/10.3390\/ijms17081365","journal-title":"Int J Mol Sci"},{"key":"4682_CR22","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/978-1-4939-9420-5_16","volume":"1981","author":"E Pose","year":"2019","unstructured":"Pose E, Sancho-Bru P, Coll M (2019) 3,5-Diethoxycarbonyl-1,4-dihydrocollidine diet: a rodent model in cholestasis research. Methods Mol Biol 1981:249\u2013257. https:\/\/doi.org\/10.1007\/978-1-4939-9420-5_16","journal-title":"Methods Mol Biol"},{"key":"4682_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.molmet.2019.11.012","volume":"31","author":"H Mziaut","year":"2020","unstructured":"Mziaut H, Henniger G, Ganss K, Hempel S, Wolk S, McChord J, Chowdhury K, Ravassard P, Knoch KP, Krautz C, Weitz J, Gr\u00fctzmann R, Pilarsky C, Solimena M, Kersting S (2020) MiR-132 controls pancreatic beta cell proliferation and survival through Pten\/Akt\/Foxo3 signaling. Mol Metab 31:150\u2013162. https:\/\/doi.org\/10.1016\/j.molmet.2019.11.012","journal-title":"Mol Metab"},{"key":"4682_CR24","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1194\/jlr.M007641","volume":"51","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Klaassen CD (2010) Effects of feeding bile acids and a bile acid sequestrant on hepatic bile acid composition in mice. J Lipid Res 51:3230\u20133242. https:\/\/doi.org\/10.1194\/jlr.M007641","journal-title":"J Lipid Res"},{"key":"4682_CR25","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/s0168-8278(05)80145-x","volume":"20","author":"Y Fukumoto","year":"1994","unstructured":"Fukumoto Y, Ando M, Yasunaga M, Okuda M, Okita K (1994) Secretin prevents taurocholate-induced intrahepatic cholestasis in the rat. J Hepatol 20:750\u2013754. https:\/\/doi.org\/10.1016\/s0168-8278(05)80145-x","journal-title":"J Hepatol"},{"key":"4682_CR26","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/s1386-6346(01)00141-3","volume":"22","author":"Y Fukumoto","year":"2002","unstructured":"Fukumoto Y, Murakami F, Tateishi A, Itoh Y, Sakaida I, Okita K (2002) Effects of secretin on TCDCA- or TDCA-induced cholestatic liver injury in the rat. Hepatol Res 22:214\u2013222. https:\/\/doi.org\/10.1016\/s1386-6346(01)00141-3","journal-title":"Hepatol Res"},{"key":"4682_CR27","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/toxsci\/kfj111","volume":"90","author":"ND Kim","year":"2006","unstructured":"Kim ND, Moon JO, Slitt AL, Copple BL (2006) Early growth response factor-1 is critical for cholestatic liver injury. Toxicol Sci 90:586\u2013595. https:\/\/doi.org\/10.1093\/toxsci\/kfj111","journal-title":"Toxicol Sci"},{"key":"4682_CR28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ajpath.2010.11.026","volume":"178","author":"K Allen","year":"2011","unstructured":"Allen K, Jaeschke H, Copple BL (2011) Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis. Am J Pathol 178:175\u2013186. https:\/\/doi.org\/10.1016\/j.ajpath.2010.11.026","journal-title":"Am J Pathol"},{"key":"4682_CR29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.taap.2009.11.013","volume":"243","author":"K Allen","year":"2010","unstructured":"Allen K, Kim ND, Moon JO, Copple B (2010) Upregulation of early growth response factor-1 by bile acids requires mitogen-activated protein kinase signaling. Toxicol Appl Pharmacol 243:63\u201367. https:\/\/doi.org\/10.1016\/j.taap.2009.11.013","journal-title":"Toxicol Appl Pharmacol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-023-04682-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-023-04682-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-023-04682-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T05:07:18Z","timestamp":1697432838000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-023-04682-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,4]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["4682"],"URL":"https:\/\/doi.org\/10.1007\/s11010-023-04682-7","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,4]]},"assertion":[{"value":"9 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors disclose no conflicts.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"We recruited patients from the Institute of Hepatobiliary Surgery and Department of Gastroenterology, The First Affiliated Hospital to Third Military Medical University (Chongqing, China). The study protocol was approved by the Institutional Ethics Review Board of The First Affiliated Hospital to Third Military Medical University, Chongqing, China (B-KY2021038). All animal studies and protocols were approved by the Institutional Animal Care and Use Committee of Third Military Medical University (AMUWEC20201580).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}